| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | PLAC | 1.01e-05 | 19 | 138 | 4 | PS50900 | |
| Domain | PLAC | 1.01e-05 | 19 | 138 | 4 | IPR010909 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF777 BCL6 RLF GFI1B ZNF668 ZNF469 ZIK1 ZNF532 CTCF ZNF257 ZBTB25 ZNF540 SP6 ZNF432 ZNF350 ZFP69B ZNF98 | 1.46e-05 | 694 | 138 | 17 | IPR013087 |
| Domain | - | ZNF777 BCL6 RLF GFI1B ZNF668 ZIK1 ZNF532 CTCF ZNF257 ZBTB25 ZNF540 SP6 ZNF432 ZNF350 ZFP69B ZNF98 | 4.24e-05 | 679 | 138 | 16 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF777 BCL6 RLF GFI1B ZNF668 ZNF469 ZIK1 ZNF532 CTCF ZNF257 ZBTB25 ZNF540 SP6 ZNF432 ZNF350 ZFP69B ZNF98 | 5.88e-05 | 775 | 138 | 17 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF777 BCL6 RLF GFI1B ZNF668 ZNF469 ZIK1 ZNF532 CTCF ZNF257 ZBTB25 ZNF540 SP6 ZNF432 ZNF350 ZFP69B ZNF98 | 6.07e-05 | 777 | 138 | 17 | PS00028 |
| Domain | Znf_C2H2-like | ZNF777 BCL6 RLF GFI1B ZNF668 ZNF469 ZIK1 ZNF532 CTCF ZNF257 ZBTB25 ZNF540 SP6 ZNF432 ZNF350 ZFP69B ZNF98 | 8.16e-05 | 796 | 138 | 17 | IPR015880 |
| Domain | Znf_C2H2 | ZNF777 BCL6 RLF GFI1B ZNF668 ZNF469 ZIK1 ZNF532 CTCF ZNF257 ZBTB25 ZNF540 SP6 ZNF432 ZNF350 ZFP69B ZNF98 | 9.35e-05 | 805 | 138 | 17 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF777 BCL6 RLF GFI1B ZNF668 ZNF469 ZIK1 ZNF532 CTCF ZNF257 ZBTB25 ZNF540 SP6 ZNF432 ZNF350 ZFP69B ZNF98 | 9.79e-05 | 808 | 138 | 17 | SM00355 |
| Domain | Ryanodine_rcpt | 1.62e-04 | 3 | 138 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.62e-04 | 3 | 138 | 2 | IPR009460 | |
| Domain | RyR | 1.62e-04 | 3 | 138 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.62e-04 | 3 | 138 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.62e-04 | 3 | 138 | 2 | IPR013333 | |
| Domain | zf-C2H2 | ZNF777 BCL6 RLF GFI1B ZNF668 ZNF469 ZIK1 CTCF ZNF257 ZNF540 SP6 ZNF432 ZNF350 ZFP69B ZNF98 | 1.90e-04 | 693 | 138 | 15 | PF00096 |
| Domain | Pep_M12B_propep | 1.92e-04 | 39 | 138 | 4 | PF01562 | |
| Domain | Peptidase_M12B_N | 1.92e-04 | 39 | 138 | 4 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 2.12e-04 | 40 | 138 | 4 | PS00427 | |
| Domain | Reprolysin | 2.12e-04 | 40 | 138 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 2.12e-04 | 40 | 138 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.12e-04 | 40 | 138 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 2.12e-04 | 40 | 138 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 2.34e-04 | 41 | 138 | 4 | IPR001762 | |
| Domain | ADAM_spacer1 | 6.27e-04 | 23 | 138 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 6.27e-04 | 23 | 138 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 7.13e-04 | 24 | 138 | 3 | IPR013273 | |
| Domain | RIH_assoc-dom | 7.97e-04 | 6 | 138 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.97e-04 | 6 | 138 | 2 | PF08709 | |
| Domain | RIH_assoc | 7.97e-04 | 6 | 138 | 2 | PF08454 | |
| Domain | RIH_dom | 7.97e-04 | 6 | 138 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.97e-04 | 6 | 138 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.97e-04 | 6 | 138 | 2 | IPR015925 | |
| Domain | - | 7.97e-04 | 6 | 138 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.97e-04 | 6 | 138 | 2 | PF01365 | |
| Domain | CAMSAP_CH | 1.11e-03 | 7 | 138 | 2 | PF11971 | |
| Domain | CAMSAP_CH | 1.11e-03 | 7 | 138 | 2 | IPR022613 | |
| Domain | ZU5 | 1.89e-03 | 9 | 138 | 2 | SM00218 | |
| Domain | - | 1.89e-03 | 71 | 138 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 1.89e-03 | 71 | 138 | 4 | IPR000219 | |
| Domain | MIR | 2.35e-03 | 10 | 138 | 2 | PF02815 | |
| Domain | JmjN | 2.35e-03 | 10 | 138 | 2 | SM00545 | |
| Domain | MIR_motif | 2.35e-03 | 10 | 138 | 2 | IPR016093 | |
| Domain | JmjN | 2.35e-03 | 10 | 138 | 2 | PF02375 | |
| Domain | MIR | 2.35e-03 | 10 | 138 | 2 | PS50919 | |
| Domain | MIR | 2.35e-03 | 10 | 138 | 2 | SM00472 | |
| Domain | JMJN | 2.35e-03 | 10 | 138 | 2 | PS51183 | |
| Domain | ZU5 | 2.35e-03 | 10 | 138 | 2 | PS51145 | |
| Domain | Ank_3 | 2.35e-03 | 10 | 138 | 2 | PF13606 | |
| Domain | JmjN | 2.35e-03 | 10 | 138 | 2 | IPR003349 | |
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 19549818 | ||
| Pubmed | Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131. | 5.34e-06 | 110 | 138 | 6 | 26841866 | |
| Pubmed | ZNF777 MKRN2 PGR RLF TRIM16 IBTK RBM22 PBRM1 ZNF532 PCSK6 CSRP2 SP6 KDM4A | 5.39e-06 | 709 | 138 | 13 | 22988430 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9489997 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 1.56e-05 | 2 | 138 | 2 | 12640042 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 14592949 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15705893 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9799464 | ||
| Pubmed | DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas. | 1.56e-05 | 2 | 138 | 2 | 20733034 | |
| Pubmed | Ryanodine receptor-ankyrin interaction regulates internal Ca2+ release in mouse T-lymphoma cells. | 1.56e-05 | 2 | 138 | 2 | 7629097 | |
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 1.56e-05 | 2 | 138 | 2 | 17118445 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24362533 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23760269 | ||
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 1.56e-05 | 2 | 138 | 2 | 11500519 | |
| Pubmed | Three-dimensional Epigenome Statistical Model: Genome-wide Chromatin Looping Prediction. | 1.56e-05 | 2 | 138 | 2 | 29581440 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12565913 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23192870 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9192302 | ||
| Pubmed | RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events. | 1.56e-05 | 2 | 138 | 2 | 17580311 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24442343 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 7556644 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 1.56e-05 | 2 | 138 | 2 | 15894801 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20056913 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9817784 | ||
| Pubmed | Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling. | 1.56e-05 | 2 | 138 | 2 | 12709442 | |
| Pubmed | Deleterious variants in X-linked CFAP47 induce asthenoteratozoospermia and primary male infertility. | 1.56e-05 | 2 | 138 | 2 | 33472045 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17210645 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24584352 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 11278446 | ||
| Pubmed | KDM5A MKRN2 PKHD1L1 GFI1B IBTK ZNF668 PBRM1 ZBED4 CTCF CSRP1 CSRP2 KDM4A MGA | 2.14e-05 | 808 | 138 | 13 | 20412781 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 CACNA1F ANK1 PCDHGB3 DISC1 POLR2A RNF213 RYR1 ARHGEF33 ZBED4 ATM SYMPK | 3.96e-05 | 736 | 138 | 12 | 29676528 |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18403125 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 11171121 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 29861105 | ||
| Pubmed | A hierarchy of ankyrin-spectrin complexes clusters sodium channels at nodes of Ranvier. | 4.68e-05 | 3 | 138 | 2 | 25362473 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 7876312 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 30854929 | ||
| Pubmed | CFTR chloride channels are regulated by a SNAP-23/syntaxin 1A complex. | 4.68e-05 | 3 | 138 | 2 | 12209004 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18728014 | ||
| Pubmed | Ankyrin facilitates intracellular trafficking of alpha1-Na+-K+-ATPase in polarized cells. | 4.68e-05 | 3 | 138 | 2 | 18768923 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 22948152 | ||
| Pubmed | Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions. | 4.68e-05 | 3 | 138 | 2 | 35201268 | |
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 4.68e-05 | 3 | 138 | 2 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 4.68e-05 | 3 | 138 | 2 | 7621815 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 24612393 | ||
| Pubmed | Slingshot-3 dephosphorylates ADF/cofilin but is dispensable for mouse development. | 4.68e-05 | 3 | 138 | 2 | 18442045 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 4.68e-05 | 3 | 138 | 2 | 10473538 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18313230 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18434746 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25605334 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 4.68e-05 | 3 | 138 | 2 | 9204703 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21881589 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 10893266 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 4.68e-05 | 3 | 138 | 2 | 12213830 | |
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 4.68e-05 | 3 | 138 | 2 | 33410423 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 9242641 | ||
| Pubmed | Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex. | 4.68e-05 | 3 | 138 | 2 | 20861839 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25239916 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18643873 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 11159936 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 32015491 | ||
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 4.68e-05 | 3 | 138 | 2 | 34289389 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 9168116 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 4.68e-05 | 3 | 138 | 2 | 4600883 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 7635066 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 5.84e-05 | 430 | 138 | 9 | 35044719 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 22100703 | ||
| Pubmed | Immunoprecipitation techniques for the analysis of transcription factor complexes. | 9.33e-05 | 4 | 138 | 2 | 12054881 | |
| Pubmed | Activated cholinergic signaling provides a target in squamous cell lung carcinoma. | 9.33e-05 | 4 | 138 | 2 | 18559515 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 17851256 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 9.33e-05 | 4 | 138 | 2 | 23413940 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 9607712 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 37406588 | ||
| Pubmed | ADAMTS-3, -13, -16, and -19 levels in patients with habitual abortion. | 9.33e-05 | 4 | 138 | 2 | 28088271 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 28754906 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 21037240 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 23482488 | ||
| Pubmed | Insulin stimulates syntaxin4 SNARE complex assembly via a novel regulatory mechanism. | 9.33e-05 | 4 | 138 | 2 | 24469400 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 18206662 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 34180393 | ||
| Pubmed | Characterization of the murine Inpp4b gene and identification of a novel isoform. | 9.33e-05 | 4 | 138 | 2 | 16631325 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 9384575 | ||
| Pubmed | Stromal Pbrm1 mediates chromatin remodeling necessary for embryo implantation in the mouse uterus. | 9.33e-05 | 4 | 138 | 2 | 38426493 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 9815145 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 24957606 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 35379828 | ||
| Pubmed | 1.18e-04 | 472 | 138 | 9 | 38943005 | ||
| Pubmed | 1.41e-04 | 124 | 138 | 5 | 20850016 | ||
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 23918386 | ||
| Pubmed | Involvement of Munc18 isoforms in the regulation of granule exocytosis in neutrophils. | 1.55e-04 | 5 | 138 | 2 | 18588921 | |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 1.55e-04 | 5 | 138 | 2 | 19011160 | |
| Pubmed | Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression. | 1.55e-04 | 5 | 138 | 2 | 19421407 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL34 KDM5A ORC3 POLR2A RFC4 PHC3 ZNF668 RBM22 PBRM1 ZBED4 CTCF RPRD2 MGA ZMYM4 SYMPK | 2.02e-04 | 1294 | 138 | 15 | 30804502 |
| Pubmed | Host resistance to malaria: using mouse models to explore the host response. | 2.32e-04 | 6 | 138 | 2 | 21116636 | |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 2.32e-04 | 6 | 138 | 2 | 26025922 | |
| Pubmed | 2.32e-04 | 6 | 138 | 2 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 2.32e-04 | 6 | 138 | 2 | 14592808 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.32e-04 | 6 | 138 | 2 | 25966694 | |
| Pubmed | Purification and characterization of human DNA damage checkpoint Rad complexes. | 2.32e-04 | 6 | 138 | 2 | 11572977 | |
| Cytoband | 11q22-q23 | 1.33e-04 | 6 | 138 | 2 | 11q22-q23 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF777 BCL6 RLF GFI1B ZNF668 ZNF469 ZIK1 ZNF532 CTCF ZNF257 ZBTB25 ZNF540 SP6 ZNF432 ZNF350 ZFP69B ZNF98 | 1.75e-06 | 718 | 111 | 17 | 28 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.12e-04 | 3 | 111 | 2 | 287 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.03e-04 | 19 | 111 | 3 | 50 | |
| GeneFamily | Maestro heat like repeat containing | 1.98e-03 | 11 | 111 | 2 | 636 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 5.72e-07 | 183 | 138 | 9 | M2993 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN | 3.60e-06 | 171 | 138 | 8 | M6321 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP | 1.14e-05 | 200 | 138 | 8 | M6266 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.35e-07 | 158 | 138 | 7 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-07 | 160 | 138 | 7 | 9f24ee4fe1ba4590dce5dd4d43707fb007dca82f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-07 | 160 | 138 | 7 | 3b3b99305558f5b49d050fb9b249007630ea9085 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.83e-07 | 163 | 138 | 7 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.59e-07 | 168 | 138 | 7 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-06 | 176 | 138 | 7 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.76e-06 | 184 | 138 | 7 | 437bc6c983849c1c3ff85f0dee091cf7010a4665 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.76e-06 | 184 | 138 | 7 | d1d5dd1701dff4eedf1cebbb9f4cd603aa0009c1 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.89e-06 | 186 | 138 | 7 | fbc4ba4a7a8e5902a1b0add52ece0d6da85a8a5f | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.89e-06 | 186 | 138 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.03e-06 | 188 | 138 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.26e-06 | 191 | 138 | 7 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-06 | 193 | 138 | 7 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-06 | 193 | 138 | 7 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 2.96e-06 | 199 | 138 | 7 | d65847ceb68a560798df3f73e6f838e7c3e38a1c | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.56e-06 | 132 | 138 | 6 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P3|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.52e-06 | 89 | 138 | 5 | 9e7041ab9409028007fefe53db6d1048eafae93b | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Ndst4_(Subiculum)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.52e-06 | 89 | 138 | 5 | 497771687b48c7e0fa87e31962feaafd8f248b98 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.52e-06 | 89 | 138 | 5 | 436e1229ee28517c11dfe0a5d1cdad3477419e00 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.52e-06 | 89 | 138 | 5 | e7abf4af18d63c9384d25365a827e85a9adee964 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.52e-06 | 89 | 138 | 5 | 4e5f4c0404968422703c248488e6b2ee8737dc00 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 8.64e-06 | 154 | 138 | 6 | 5ff380205fa7ab97ba21f6512bc9e14c0fb320b6 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.30e-06 | 156 | 138 | 6 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 160 | 138 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 160 | 138 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 162 | 138 | 6 | d0ffebf5adee8a3ac9b81a4b793184f54010489a | |
| ToppCell | droplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 174 | 138 | 6 | cf4e0567f2a4ebe5534046b1c091af59b55bdc4f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-05 | 175 | 138 | 6 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-05 | 175 | 138 | 6 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-05 | 178 | 138 | 6 | 63f5880a5b514e20ef2c07a6a9cb8df34e6cede5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-05 | 178 | 138 | 6 | 82c84f8b8a7e6a3d3be3351b348a37143279c100 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-05 | 178 | 138 | 6 | cb91558469ae0748106fb0b6d702edb0ff21a884 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-05 | 182 | 138 | 6 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-05 | 182 | 138 | 6 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.30e-05 | 183 | 138 | 6 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 183 | 138 | 6 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-05 | 184 | 138 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-05 | 185 | 138 | 6 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | severe-Others|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.52e-05 | 186 | 138 | 6 | 234a4bc7c3529daf8804f2a366887d02a47075cd | |
| ToppCell | severe-Others-Megakaryocytes|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.59e-05 | 187 | 138 | 6 | ef16331d1e5abe6bde7f09793c4a87a6ac24e592 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.67e-05 | 188 | 138 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass | 2.67e-05 | 188 | 138 | 6 | fd70fb89570f014d1299c60fe017dc09f24e57c6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.67e-05 | 188 | 138 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.67e-05 | 188 | 138 | 6 | fe08277d5aa693a2e12786738d12ec6390e8d13d | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-05 | 188 | 138 | 6 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.75e-05 | 189 | 138 | 6 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.75e-05 | 189 | 138 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.92e-05 | 191 | 138 | 6 | 402c341b00f98e8215458766b3c219fff8dcb447 | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.92e-05 | 191 | 138 | 6 | 25dd538d6a361bd3367c8a1c0dfc9e7003061af3 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.01e-05 | 192 | 138 | 6 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-05 | 193 | 138 | 6 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.10e-05 | 193 | 138 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.10e-05 | 193 | 138 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.10e-05 | 193 | 138 | 6 | 725326d7e3604736b607c19f4069c81cb4f2d20c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-05 | 193 | 138 | 6 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | remission-CD4+_Tcm|World / disease stage, cell group and cell class | 3.28e-05 | 195 | 138 | 6 | 365a06e2fb48ec5262a4e2580ba5a592e48127e0 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.28e-05 | 195 | 138 | 6 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 3.28e-05 | 195 | 138 | 6 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.28e-05 | 195 | 138 | 6 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-05 | 196 | 138 | 6 | cda3681f032f740cb09c64c62b9153cb62dbb5d2 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Teffector/EM_CD4|Liver / Manually curated celltypes from each tissue | 3.38e-05 | 196 | 138 | 6 | 88cafaac9530c648b3ef5ad04b79c7bed8978bb6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 196 | 138 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-05 | 196 | 138 | 6 | b55aa507429ddce89ad4f42ab6daeca2f34fd676 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-05 | 196 | 138 | 6 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-05 | 196 | 138 | 6 | 1d94cecd378a829dd8014fc086d7fca48c953a91 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-05 | 196 | 138 | 6 | aacec48285bcb7ccf1b538187071885e3602cc49 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Severe / Disease group, lineage and cell class | 3.47e-05 | 197 | 138 | 6 | 07f74bdadfd28e1d55b3f4a3bf87d5dd65a2e9c5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.47e-05 | 197 | 138 | 6 | 9f0d91bb7aec4f2442259eca1ddf7905f8d40e9b | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-Teffector/EM_CD4|bone_marrow / Manually curated celltypes from each tissue | 3.47e-05 | 197 | 138 | 6 | 73a13d4dc76476f3a38b09b776779c5b7d67171f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.47e-05 | 197 | 138 | 6 | 258dfe69b5faeaee709422f873b144ca5e4a6452 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 197 | 138 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.47e-05 | 197 | 138 | 6 | bf80e39cd68fd5bb85c8726d4f82648391de74ad | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.47e-05 | 197 | 138 | 6 | 296b27348ca7e9acf746f752cf810e4e5baea76c | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.47e-05 | 197 | 138 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.57e-05 | 198 | 138 | 6 | 89986c7756541df364df516329d10775ba0e78a4 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.57e-05 | 198 | 138 | 6 | c7075dce915ab8387309fcb12c5f6a17d4100cda | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 198 | 138 | 6 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.57e-05 | 198 | 138 | 6 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.67e-05 | 199 | 138 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-05 | 199 | 138 | 6 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | Caecum-(1)_T_cell-(16)_Tfh|Caecum / shred on region, Cell_type, and subtype | 3.67e-05 | 199 | 138 | 6 | d07d77ae426dd1164d80d7031f14befa0369d3e5 | |
| ToppCell | Caecum-T_cell-Tfh|Caecum / Region, Cell class and subclass | 3.67e-05 | 199 | 138 | 6 | fb40f37d842f170ed101dfa3bffdb8f3b2c94f19 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-05 | 199 | 138 | 6 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_naive|COVID-19_Severe / Disease, condition lineage and cell class | 3.78e-05 | 200 | 138 | 6 | 1fb96090b5205e95ec21378bf4b88eec7257cf7e | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD4+_Tcm|COVID-19_Convalescent / Disease, condition lineage and cell class | 3.78e-05 | 200 | 138 | 6 | 99c5abfe96d791c60ae6021ab4201851ee4afc47 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.93e-05 | 128 | 138 | 5 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | COVID-CD4-proli_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.08e-04 | 151 | 138 | 5 | dd40dfc5b1211d31607e16d9b433a5c1796e7edf | |
| ToppCell | IIH-Treg|IIH / Condition, Cell_class and T cell subcluster | 1.15e-04 | 153 | 138 | 5 | 17704e18833812fcf2a2727b1e3f8a9984ba5b59 | |
| ToppCell | IIH-Treg-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 1.18e-04 | 154 | 138 | 5 | d2211a892654b92decb208969040920f7ae8ba1e | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.22e-04 | 155 | 138 | 5 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 156 | 138 | 5 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 156 | 138 | 5 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.26e-04 | 156 | 138 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 1.26e-04 | 156 | 138 | 5 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 1.29e-04 | 157 | 138 | 5 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.69e-07 | 195 | 133 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ADAMTS19 ANK1 RFC4 ADAM12 ALS2CL INPP4B PGR ZNF668 PBRM1 ZNF532 ZNF432 MROH7 ZFYVE26 ATM HERC2 GGA1 VPS13B PLEKHA8 | 1.67e-06 | 1074 | 133 | 18 | C0006142 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Schizophrenia | CACNA1F ANK3 ADAMTS3 DISC1 MC5R F2 ADAM12 ALS2CL CFAP65 ADAMTS12 PBRM1 CTCF ATM | 1.85e-04 | 883 | 133 | 13 | C0036341 |
| Disease | response to trauma exposure, post-traumatic stress disorder symptom measurement | 2.00e-04 | 5 | 133 | 2 | EFO_0008483, EFO_0008535 | |
| Disease | Nonorganic psychosis | 2.72e-04 | 69 | 133 | 4 | C0349204 | |
| Disease | pyridoxate measurement | 3.67e-04 | 31 | 133 | 3 | EFO_0010527 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 4.42e-04 | 33 | 133 | 3 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | Prostatic Neoplasms | 4.96e-04 | 616 | 133 | 10 | C0033578 | |
| Disease | hypertension | 5.02e-04 | 307 | 133 | 7 | EFO_0000537 | |
| Disease | basophil percentage of granulocytes | 5.50e-04 | 83 | 133 | 4 | EFO_0007995 | |
| Disease | female breast cancer (is_implicated_in) | 5.55e-04 | 8 | 133 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 8.42e-04 | 41 | 133 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 8.42e-04 | 41 | 133 | 3 | C0858252 | |
| Disease | alopecia areata (is_marker_for) | 8.86e-04 | 10 | 133 | 2 | DOID:986 (is_marker_for) | |
| Disease | thrombosis (implicated_via_orthology) | 8.86e-04 | 10 | 133 | 2 | DOID:0060903 (implicated_via_orthology) | |
| Disease | endometrial neoplasm | 1.08e-03 | 11 | 133 | 2 | EFO_0004230 | |
| Disease | pulmonary fibrosis | 1.08e-03 | 11 | 133 | 2 | EFO_0009448 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | Adenoid Cystic Carcinoma | 1.11e-03 | 100 | 133 | 4 | C0010606 | |
| Disease | Psychotic Disorders | 1.15e-03 | 101 | 133 | 4 | C0033975 | |
| Disease | nervous system disease (implicated_via_orthology) | 1.29e-03 | 12 | 133 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | fetal genotype effect measurement, body weights and measures | 1.42e-03 | 49 | 133 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | Malignant neoplasm of prostate | 1.96e-03 | 616 | 133 | 9 | C0376358 | |
| Disease | Chronic Lymphocytic Leukemia | 1.98e-03 | 55 | 133 | 3 | C0023434 | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | idiopathic pulmonary fibrosis | 2.19e-03 | 57 | 133 | 3 | EFO_0000768 | |
| Disease | cutaneous melanoma | 2.23e-03 | 121 | 133 | 4 | EFO_0000389 | |
| Disease | T-Cell Lymphoma | 2.32e-03 | 16 | 133 | 2 | C0079772 | |
| Disease | behavioural inhibitory control measurement | 2.32e-03 | 16 | 133 | 2 | EFO_0008467 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 2.32e-03 | 16 | 133 | 2 | C0334634 | |
| Disease | basophil measurement | 2.54e-03 | 60 | 133 | 3 | EFO_0803539 | |
| Disease | disease progression measurement | 2.66e-03 | 61 | 133 | 3 | EFO_0008336 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.92e-03 | 63 | 133 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | neck circumference | 3.28e-03 | 19 | 133 | 2 | EFO_0011043 | |
| Disease | skin sensitivity to sun | 3.28e-03 | 19 | 133 | 2 | EFO_0004795 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 3.28e-03 | 19 | 133 | 2 | EFO_0000220, GO_0097327 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 3.63e-03 | 20 | 133 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | Hemorrhage | 3.63e-03 | 20 | 133 | 2 | C0019080 | |
| Disease | Granulomatous Slack Skin | 4.39e-03 | 22 | 133 | 2 | C0376407 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DKCFLSATECLQKIM | 831 | Q60I27 | |
| LTEKEIFESCVCKLM | 581 | P13569 | |
| IFESCVCKLMANKTR | 586 | P13569 | |
| VCSKCGKTFTRRNTM | 556 | P49711 | |
| IDKICFSSIMKCDTG | 271 | Q9BYD9 | |
| LRCYCMTDDKVDKTL | 1256 | P16157 | |
| FRTTFKMLLLCQCDK | 551 | P20309 | |
| EYALEEKVKSCRCSM | 51 | A8MVX0 | |
| TCKVCMDKEVSIVFI | 556 | Q13489 | |
| SKSSFAKCEMRDAKC | 566 | O43184 | |
| MVQTFSRCILCSKDE | 356 | Q8WUY9 | |
| MSKRLRSSEVCADCS | 1 | Q14161 | |
| VCRIFYDMKVRKCST | 11 | P60981 | |
| TTKVCMSEKFCSTLR | 561 | Q9NRI5 | |
| CRMVTRKLETQKCAA | 2826 | Q8IZT6 | |
| ASFCQTLKAMKKCSV | 1546 | P58397 | |
| DCAKFLTTIKCMQTI | 111 | Q7Z713 | |
| KVCSICMEVILEKAS | 236 | Q9H000 | |
| SQKCVKTLLRCSYFM | 1146 | Q68CQ1 | |
| VRMRFKKTEVCQTCS | 61 | Q9NW64 | |
| SLAMLEKTVEKCCIS | 86 | Q99638 | |
| AVRTRQALCCKMSVE | 116 | Q9Y644 | |
| LSGMCSEKRKCIIAE | 456 | Q8TE59 | |
| ALASCTRCLNKIMKT | 491 | O60840 | |
| MRSTEARKKAFATCS | 226 | Q8NG77 | |
| MTCILGKCAVLSFKD | 1226 | Q86U86 | |
| SAFATLFTVMCRKKQ | 311 | Q8NFM7 | |
| CMFGCTCLKRKVVLV | 1076 | Q8IWI9 | |
| TCCSRKMEEKYQLTA | 71 | P51654 | |
| KITVQFSDMRTCRVC | 2241 | O95714 | |
| PSCKVTAMKCFLLEL | 81 | P40933 | |
| QKKCSFLCDVTMKSV | 761 | Q9P2D0 | |
| ECRMCGKAFKRSSTL | 221 | Q5VTD9 | |
| TITDMKVKKRTCCTA | 1551 | Q6ZU64 | |
| CCKSAKDRTSMSVTL | 841 | O15327 | |
| ITKEKMTDICRSCGF | 971 | Q9UPZ3 | |
| RMPCSVLTLAKTKSC | 671 | Q8NDZ0 | |
| LCMVCKKNLDSTTVA | 36 | P21291 | |
| ALLMVLVVLSCKSSC | 6 | P01562 | |
| TFCEMVKSNRLCERK | 941 | P29122 | |
| MRSTEARKKAFATCS | 226 | A6NH00 | |
| AKTKEICSRVLCMFS | 306 | Q8NGF3 | |
| LVKEKSCRMSATQCL | 751 | Q32MK0 | |
| SCFELEKLCRFIMSV | 491 | Q9Y233 | |
| LESGVCMKAVCKRVA | 96 | A6NFU8 | |
| CSCRKDMVKISMDVF | 306 | O75164 | |
| ALTVLETCMKSCGKR | 66 | Q9UJY5 | |
| KSTCNTFLKTLEECM | 156 | Q96JA3 | |
| LVSCKRVFRELKMLC | 176 | Q9UBE8 | |
| KTRSCSMLCKALSTC | 226 | P58182 | |
| MRSTEARKKAFATCS | 226 | Q8NG76 | |
| CGKKSTCVLEFEMVA | 96 | Q9Y5G1 | |
| LCKSFRNSLISMLKC | 301 | Q9H244 | |
| ISVLKSVSMACLACI | 121 | Q9Y2T5 | |
| EFLRSKRFCTMSCAK | 796 | Q8NDX5 | |
| VKFCICRKTASGFML | 1161 | P29375 | |
| SVTCRKAVLDCEAMK | 16 | Q7Z6M3 | |
| VLTCGSCKVFFKRAM | 581 | P06401 | |
| FFRCCLDKKSQRTML | 1896 | Q13315 | |
| KCIELSCGSVRKMRD | 456 | P50993 | |
| KMCTAFRTFDPCKQL | 491 | O15072 | |
| KLRTSLDSCQACMKI | 561 | B1AJZ9 | |
| LCMVCRKNLDSTTVA | 36 | Q16527 | |
| KKCRMESCFDFTLCK | 96 | Q16394 | |
| RSKTKCLFIQMEFCD | 356 | P19525 | |
| CYSLKCNLEKERMTT | 441 | Q4L180 | |
| KFKAQETRMVALCTC | 86 | P0C7P0 | |
| SSLRCFCMTDDKVDK | 1326 | Q12955 | |
| CRKFIKASEAEMVSA | 121 | P41182 | |
| TRMKVSKSCVPRCFE | 56 | P0DP58 | |
| EMRKTFKEIICCRGF | 301 | P33032 | |
| LMEKCSELSAVTERC | 186 | Q1MX18 | |
| MIFSLASCIITAKLC | 271 | Q6UW02 | |
| VKCAVKDTYSCFIMR | 21 | Q30KQ1 | |
| FSLCQLSCVSKLMRD | 631 | Q8TB52 | |
| TMRVDVCSTETLKCL | 216 | Q5VT52 | |
| KEIRFPKMVTSCCRF | 2221 | P21817 | |
| SCTPKKKCSIVIEMS | 1676 | Q6ZTR5 | |
| LTCDTKTICKDVFDM | 586 | Q12923 | |
| LISQLMDCCVDIKSK | 151 | Q9UBD5 | |
| SMCAKCVRDRIKRAF | 81 | P49207 | |
| MCSTLKKCGTYRTEV | 1 | Q9GZY0 | |
| CASSRIAKVVCMEFS | 1061 | A6NES4 | |
| MVSTKIQDTKGCRAC | 596 | Q92918 | |
| MEFLKTCVLRRNACT | 1 | Q8WWV3 | |
| CGMITKREAERLCKS | 151 | P84550 | |
| TMEKESKTTRFCLIC | 166 | P35249 | |
| KRSFKMADLGLTECC | 971 | Q58EX7 | |
| CSTLTSKCLLLKARM | 66 | P09758 | |
| VCKVVESSSIFCLKM | 691 | Q587J7 | |
| VEAFTSRCCEVLKVM | 41 | Q5SWL8 | |
| MRETEKTLTELNKCC | 66 | O00161 | |
| VELKSRMLESLSCEC | 66 | Q96EA4 | |
| TKKFPCAVCSRVFMR | 311 | Q3SY56 | |
| KARCLSCTSMVLKGI | 151 | A4IF30 | |
| TTKLLASCCKMTDLL | 41 | O00186 | |
| RCCKATEKRMSGLSE | 251 | Q9UNH6 | |
| KMKELSVLSLICSCF | 11 | Q9NZ72 | |
| SVMKLCVIIAKSCDA | 676 | O75969 | |
| IVCCIDAFVVTTKMR | 121 | Q8IZ96 | |
| FSFSRKRKMSCTICG | 341 | P24278 | |
| FEAVMRTLCECKETA | 3971 | Q63HN8 | |
| KCSMCDTVFTLQTLL | 906 | Q9HCE3 | |
| MASCITQRKCKVTAT | 111 | Q969E8 | |
| CKECGKAFMLRSVLT | 441 | Q8NDQ6 | |
| AFSRIMKLCEEKCET | 161 | Q70EL2 | |
| FVCRECKETFSTMTL | 516 | Q96K58 | |
| SSLKEKCSSMAVCFD | 936 | Q13129 | |
| LCTKERMICLEFTSR | 521 | Q76I76 | |
| TLSLVMSQCCRKIKD | 56 | Q96G75 | |
| KSQIAFPKMVASCCR | 2081 | Q15413 | |
| VKTMKVLRCVCFFCS | 101 | P24928 | |
| LKEAAVKTCLVCMAS | 111 | Q14258 | |
| RASYVKCCLFCMSLK | 151 | Q3SY52 | |
| DETKREMKLGTCVSC | 666 | Q8WWQ8 | |
| DCVDMVCDAKRKSFL | 3671 | Q86WI1 | |
| MIITCSTKVCSFGKQ | 326 | Q15561 | |
| KCDMKSIIKATNLCF | 956 | Q92797 | |
| LICQVLRKACSSKMD | 186 | Q9P2E3 | |
| CELCATVMRIIKKSF | 3376 | Q96JG9 | |
| TVMRIIKKSFACSSC | 3381 | Q96JG9 | |
| CSLCEKAFSRKFMLT | 236 | Q9GZX5 | |
| RSYTKMKTFECNICE | 271 | Q9UJL9 | |
| VKSQMKCVVLCTDAS | 481 | Q6P2C0 | |
| LKCTCTISMAEFNLL | 646 | Q7Z7G8 | |
| FICSECGKVFTMKSR | 261 | O94892 | |
| SFKCKECEKSFCMLS | 181 | A6NK75 | |
| CKDSTRIRITDNMFC | 536 | P00734 | |
| RVKAVKSCLTCMVNY | 86 | O95361 | |
| MKLTCERCSRNFCIK | 111 | Q8WV99 | |
| FTCMECGKSFRLKIN | 546 | Q9ULD5 | |
| LVCSSCSTKKMVVEG | 1841 | Q68DK2 | |
| CALCKSLRSSAEMIE | 531 | Q5VZL5 | |
| IFMITKCCLFCFRKL | 506 | O75795 | |
| LFLQCELTLCTKMEK | 701 | Q03167 | |
| SSCSVLLTVCCMKRK | 481 | Q6UXF1 | |
| FTRVTSCKVCQMLLR | 521 | Q9UKW4 | |
| STKAICMYCVKEFSR | 131 | O75132 | |
| KECGKSFCMLSQLTR | 176 | Q9Y2Q1 | |
| ARTEVMQKSCSCKFL | 56 | Q96L42 | |
| VTLNSLFLRKDMCSC | 1586 | Q9NQX4 |